Is AHCO or AIDX more undervalued in 2026?

CirclFi compares AdaptHealth Corp. (AHCO) and 20/20 Biolabs, Inc. (AIDX) using 13 institutional-grade valuation models. AHCO has a Quality of Company score of 6.6/10 while AIDX scores 5.6/10.

Which is a better buy — AHCO or AIDX?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do AHCO and AIDX valuations compare?

AHCO at $10.13 and AIDX at $0.87 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

AHCO vs AIDX Valuation Comparison 2026 — Intrinsic Value Analysis

AHCO

Medical Devices

AdaptHealth Corp.

Quality

6.6

out of 10

Value Trap

LOW

Price

$10.13

Last close

Models

12/13

Active

AIDX

Medical Devices

20/20 Biolabs, Inc.

Quality

5.6

out of 10

Value Trap

—

Price

$0.87

Last close

Models

10/13

Active

Model-by-Model Comparison

Model	Type	AHCO Fair Value	AHCO Upside	AIDX Fair Value	AIDX Upside
Bayesian DCF	Intrinsic	$3.26	-67.9%	$0.40	-53.6%
Earnings Power Value	Intrinsic	$9.20	-9.2%	$0.22	-86.1%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for AHCO vs AIDX — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

AHCO vs AIDX — Which Stock Is More Undervalued?

AHCO scores higher with a 6.6/10 quality rating vs AIDX's 5.6/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing AdaptHealth Corp. (AHCO) and 20/20 Biolabs, Inc. (AIDX) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

AHCO currently trades at $10.13 with a QOC of 6.6/10, while AIDX trades at $0.87 with a QOC of 5.6/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).